Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor.
D000328:Adult; D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007610:Kallikreins / Q000037:antagonists & inhibitors; D008875:Middle Aged; D010919:Placebos; D014361:Trypsin Inhibitors; D014581:Urticaria / Q000188:drug therapy*
D010919:Placebos; D014361:Trypsin Inhibitors; D007611:Aprotinin; D007610:Kallikreins; D005341:Fibrinolysin